  **Abbreviations, acronyms & symbols**   
  --------------------------------------- ---------------------------------------
  AF                                      Atrial fibrillation
  ARF                                     Acute renal failure
  CABG                                    Coronary artery bypass grafting
  CCU                                     Coronary care unit
  COPD                                    Chronic obstructive pulmonary disease
  CPB                                     Cardiopulmonary bypass
  CRF                                     Chronic renal failure
  DM                                      Diabetes mellitus
  ECG                                     Ele ctroc ardi ograms
  FURB                                    Regional University of Blumenau
  ICU                                     Intensive care units
  PTCA                                    Percutaneous transluminal angioplasty
  PVD                                     Peripheral vascular disease

INTRODUCTION
============

Atrial fibrillation (AF) is a common complication after cardiac surgery, affecting about 10% to 40% of patients undergoing Coronary Artery Bypass Grafting (CABG)^\[[@r01]-[@r03]\]^. This arrhythmia occurs most frequently in the first five days of the postoperative period, peaking between 24 and 72 hours, being uncommon after the first week^\[[@r03],[@r04]\]^.

The postoperative AF represents a four-fold increased risk of stroke in comparison to the evolution of patients who remain in sinus rhythm^\[[@r05]\]^. It is meaningfully associated with postoperative complications, such as heart failure, hypoxia, hypovolemia, sepsis and electrolyte disturbances^\[[@r06]\]^, as well as it doubles the overall mortality rate in the postoperative period^\[[@r07]\]^. Such complications increase significantly the cost of surgical treatment by extending the hospital stay, present higher readmission in Intensive Care Units (ICU), prolong the duration of mechanical ventilation, increase the need for vasoactive drugs, ventricular assist devices and even reintubation^\[[@r08]\]^.

The onset of AF after cardiac surgery is associated with preoperative, intraoperative and postoperative factors^\[[@r09]\]^. Among the preoperative clinical findings, advanced age is considered an independent predictor of AF^\[[@r02],[@r03]\]^, present in about 50% of patients older than 80 years-old^\[[@r04]\]^. The intraoperative factors can be consequent to cardiac ischemia and inflammation inherent to the complexity of the surgical technique. In these situations, the time of aortic clamping, handling and atrial cannulation and the use of cardiopulmonary bypass (CPB) are reported as factors that support the installation of AF^\[[@r08]\]^. The CABG with CPB (on-pump CABG) appears to be associated with a higher incidence of AF in the postoperative compared to off-pump CABG. However, some studies reported no relevant difference in the incidence of this arrhythmia regarding the use or not of CPB^\[[@r04]\]^. Some of the conditions associated with the onset of AF after surgery include: infections, prolonged mechanical ventilation, hemodynamic instability, myocardial ischemia and low cardiac output in the postoperative period^\[[@r10]\]^.

The prevalence of AF, its impact on the health system costs and the patients\' recovery justify the demand for clarification of triggers and therapeutic procedures to reduce AF in the postoperative period. In this context, the off-pump CABG has been explored as an emerging technique that can reduce the adverse effects of the on-pump technique, which predisposes to AF. The number of off-pump procedures performed has increased significantly in recent years. However, definitive conclusions about the incidence of AF in on-pump and in off-pump CABG surgeries have not been well established yet^\[[@r11],[@r12]\]^.

The objective of this study is to determine the incidence of AF in the postoperative period of patients undergoing on-pump and off-pump CABG and to identify predictors of risk associated with the development of this arrhythmia.

METHODS
=======

A retrospective cohort study was conducted with 230 consecutive medical records of patients that underwent on-pump and off-pump CABG from January 2011 to October 2013 in the Heart Surgery Service of Santa Isabel Hospital, in Blumenau, Santa Catarina, Brazil. The respective protocol was approved by the Ethics Committee on Human Research of the Regional University of Blumenau (FURB) under number 203/12.

Inclusion criteria:

1.  \- All patients undergoing elective CABG.

2.  Exclusion criteria:

3.  · Chronic AF and/or other cardiac arrhythmias documented.

4.  · Heart valve disease.

5.  · Emergency surgery.

6.  · Cardiac reoperation.

They were divided in two groups: patients undergoing on-pump CABG (96 patients) and patients undergoing off -pump CABG (134 patients). Data were grouped in preoperative, intraoperative, and postoperative variables. Subsequently, the variables were evaluated in a comparative way.

The preoperative variables were: age, sex, smoking, Diabetes Mellitus (DM), hypertension, dyslipidemia, Peripheral Vascular Disease (PVD), use of medications (statins and/or beta-blockers), Chronic Obstructive Pulmonary Disease (COPD), extra cardiac artery disease, Acute Renal Failure (ARF) or Chronic Renal Failure (CRF), neurological dysfunction, prior and acute Percutaneous Transluminal Angioplasty (PTCA) or chronic coronary insufficiency. The EuroSCORE was calculated for all patients.

The perioperative variables were: complications (increased bleeding, hemodynamic instability, arrhythmias, need for pacemaker and/or intra-aortic balloon, acute myocardial infarction), number of grafts, the need for transfusion (packed red blood cells, fresh frozen plasma and platelets), use of vasoactive drugs (noradrenaline, dobutamine, dopamine, nitroglycerin and/or sodium nitroprusside), CPB time (in minutes), aortic clamping time (in minutes) and mortality. It is important to emphasize that each case was individually analyzed for the need of blood transfusion, taking into account the hemodynamic conditions, the volume of bleeding, the patient\'s age and history of bleeding disorders. Generically, the bleeding was considered significant when the delivery of chest tubes in the immediate postoperative period was 150 mL/h for more than 3 consecutive hours, or output rate greater than 500 mL in 6 hours, or output rate greater than 1000 mL in 24 hours.

The postoperative variables were: Coronary Care Unit (CCU) time, hospital stay, use of vasoactive drugs (noradrenaline, dobutamine, dopamine, nitroglycerin and/or sodium nitroprusside), use of medications (statins and/or beta-blockers) and need for blood products. The complications in the CCU considered were: increased bleeding, need for reoperation, infection (in the surgical wound, pneumonia and/or sepsis), neuropsychiatric (ischemic stroke, delirium and/or altered levels of consciousness), ARF, acute abdomen, pneumothorax, haematological disorders (anemia and/or thrombocytopenia), cardiac disorders (hemodynamic instability, pericarditis, cardiorespiratory arrest, myocardial infarction, circulatory shock and/or use of intra-aortic balloon) and mortality.

The analyzed outcome was the incidence of postoperative AF in on-pump and off-pump CABG. The presence of AF in the postoperative period was determined by analysis of electrocardiograms (ECG) present in the medical records. All patients undergoing CABG in this study underwent 12-lead ECG in the immediate postoperative period, every 24 hours during hospitalization in CCU and in the infirmary, and 24 hours prior to discharge.

Data were organized in descriptive tables containing: frequency, mean and standard deviation. The average and proportions estimate were made with a 95% confidence interval. In order to compare the frequencies within the same distribution, it was used the Chi-Squared test of adherence. For the association of categorical variables with the groups, it was used Chi-Squared test of independence in cases of frequencies equal to or greater than 5, and Fisher\'s exact test, in cases of frequencies below 5. For the analysis of continuous variables the Student t test was used. In all tests, the significance is considered when *P* value \< 0.05. Data analysis was performed on Microsoft Excel 2010 software and EpiInfo version 7, 2012.

The off-pump CABG has become the preferred technique at this service since 2008. It is currently used in approximately 80% of CABG surgery. During the study period, the main criterion used to display on-pump and off-pump CABG was the experience of surgeons. Regarding the surgical data, all patients were submitted to balanced general anesthesia. In the off-pump group, 362 arterial and venous grafts were performed, and about 3 grafts per patient. In this technique, no drug was used for myocardial protection and reperfusion with \"bypass\" was held only in the proximal right coronary anastomoses. In the on-pump group, 275 arterial and venous grafts were performed, and about 3 grafts per patient. Nipro oxygenator and Saint Thomas Braille cardioplegia for myocardial protection were used. The patients in this group underwent systemic hypothermia 30-32ºC.

The preoperative variables are shown in [Table 1](#t02){ref-type="table"}. Fifty-six (24.3%) out of the 230 patients, were female and 174 (75.7%) were male. The average age of patients undergoing on-pump CABG was 59.91±8.62 years-old and off-pump was 57.16±9.01 years-old (*P*=0.0213). Thirty-five patients were younger than 50 years-old, 26 (19.4%) from the group that underwent off-pump surgery and 9 (9.4%) from the group undergoing on-pump CABG, with significant differences between both groups (*P*=0.0360). The other preoperative variables are equally distributed between the groups (*P*\>0.05). The average EuroSCORE for the on-pump group was 3.37%±3.08% and for the off-pump group was 3.13%±3% (*P*=0.5468).

###### 

Preoperative variables of patients undergoing on-pump and off-pump coronary artery bypass grafting.

  Technical Features                      On-Pump (n=96)   Off-Pump (n=134)   *P* Value
  --------------------------------------- ---------------- ------------------ -----------
  Age (years) (mean±SD)                   (59.91±8.62)     (57.16±9.01)       0.0213
  Age \< 50                               9 (9.4%)         26 (19.4%)         0.0360
  50 ≤ i \< 60                            43 (44.8%)       52 (38.8%)         0.3632
  60 ≤ i \< 70                            31 (32.3%)       45 (33.6%)         0.8374
  70 ≤ i \< 80                            11 (11.5%)       10 (7.5%)          0.2995
  Age ≥ 80                                2 (2.1%)         1 (0.7%)           \-
  Female patients                         23 (24.2%)       33 (24.6%)         0.9424
  EuroSCORE                               (3.37%±3.08%)    (3.13%±3%)         0.5468
  Statins                                 87 (90.6%)       120 (89.6%)        0.7891
  Beta-blocker                            87 (90.6%)       111 (82.8%)        0.0923
  Chronic coronary insufficiency          45 (46.9%)       73 (54.5%)         0.2553
  Prior percutaneous angioplasty          30 (31.25%)      36 (26.87%)        0.4685
  Diabetes Mellitus                       30 (31.25%)      47 (35.07%)        0.5444
  Hypertension                            73 (76.04%)      107 (79.85%)       0.4898
  Dyslipidemia                            64 (66.67%)      86 (64.18%)        0.6961
  Peripheral vascular disease             4 (4.17%)        9 (6.72%)          0.4089
  Cerebrovascular disease                 6 (6.25%)        11 (8.21%)         0.5755
  Arteriopathy extracardiac               61 (63.54%)      73 (54.48%)        0.1692
  Acute or chronic renal failure          6 (6.25%)        8 (5.97%)          0.9302
  Chronic obstructive pulmonary disease   8 (8.3%)         13 (9.7%)          0.7224
  Smokers                                 23 (24%)         30 (22.4%)         0.2539

RESULTS
=======

The intraoperative variables are shown in [Table 2](#t03){ref-type="table"}. It was observed a higher consumption of blood products in the on-pump when compared to off-pump CABG (64.58% vs. 20.9%; *P*\<0.001), mainly represented by red blood cell units (2.35±0.89 in the on-pump group and 1.71±0.73 in the off-pump group; *P*=0.0164). Off-pump group showed higher tendency to develop AF, however there was no statistical difference between groups (*P*=0.0560). The other intraoperative variables are equally distributed between the groups (*P*\>0.05) and there were no deaths in this period.

###### 

Intraoperative variables of patients undergoing on-pump and off-pump coronary artery bypass grafting.

  Technical Features               On-Pump (n=96)   Off-Pump (n=134)   *P* Value
  -------------------------------- ---------------- ------------------ -----------
  Number of grafts (Mean±SD)       (2.86±0.75)      (2.7±0.86)         0.1357
  Blood products                   62 (64.58%)      28 (20.9%)         0.0000
  Packed red blood cells (units)   (2.35±0.89)      (1.71±0.73)        0.0164
  Fresh frozen plasma (units)      (2.74±0.89)      (2.42±0.51)        0.0957
  Platelets (units)                (8.6±3.66)       (7.33±2.52)        0.5911
  Sympathomimetic drugs            41 (42.71%)      58 (43.28%)        0.9308
  Dobutamine                       26 (27.08%)      40 (30.08%)        0.6218
  Noradrenaline                    11 (11.46%)      17 (12.78%)        0.7629
  Dopamine                         10 (10.42%)      10 (7.46%)         0.4330
  Vasodilators drugs               22 (22.92%)      29 (21.64%)        0.8185
  Nitroglycerine                   7 (7.29%)        12 (8.96%)         0.6513
  Sodium nitroprusside             18 (18.75%)      18 (13.53%)        0.2846
  Complications                    27 (28.13%)      46 (34.33%)        0.3189
  Increased bleeding               5 (5.21%)        6 (4.48%)          0.7979
  Hemodynamic instability          13 (13.54%)      20 (14.93%)        0.7678
  Arrhythmias                      9 (9.38%)        23 (17.16%)        0.0923
  Atrial fibrillation              1 (1.04%)        8 (6.02%)          0.0560
  Pacemaker                        2 (2.08%)        1 (0.75%)          0.3781
  Intra-aortic balloon             \-               3 (2.24%)          0.1400
  Acute myocardial infarction      \-               3 (2.24%)          0.1400
  Mortality                        \-               \-                 \-

Postoperative variables are shown in [Table 3](#t04){ref-type="table"}. The group undergoing on-pump CABG showed a higher incidence of anemia, when compared to the off-pump group (27.08% vs. 16.42%, *P*=0.0497). On-pump group also presented major bleeding when compared to off-pump group (12.5% vs. 2.99%, *P*=0.0052). For other events there was no statistical difference (*P*\>0.05).

###### 

Postoperative variables of patients undergoing on-pump and off-pump coronary artery bypass grafting.

  Technical Features                         On-Pump (n=96)   Off-Pump (n=134)   *P* Value
  ------------------------------------------ ---------------- ------------------ -----------
  Atrial Fibrillation                        19 (19.79%)      18 (13.43%)        0.1955
  Sympathomimetic drugs                      57 (59.38%)      76 (56.72%)        0.6872
  Dobutamine                                 28 (29.17%)      43 (32.09%)        0.6361
  Noradrenaline                              43 (44.79%)      48 (35.82%)        0.1701
  Dopamine                                   3 (3.13%)        4 (2.99%)          0.9514
  Adrenalin                                  1 (1.04%)        \-                 0.2364
  Vasodilators drugs                         43 (44.79%)      63 (47.01%)        0.7387
  Nitroglycerine                             28 (29.17%)      53 (39.55%)        0.1039
  Sodium nitroprusside                       25 (26.04%)      25 (18.66%)        0.1806
  Statins                                    91 (94.79%)      127 (94.78%)       0.9958
  Beta-blocker                               85 (88.54%)      118 (88.06%)       0.9108
  Blood products                             27 (28.13%)      25 (18.66%)        0.0905
  Complications coronary care unit                                                
  Increased bleeding                         12 (12.5%)       4 (2.99%)          0.0052
  Reoperation                                \-               1 (0.75%)          0.3963
  Infectious complications                   8 (8.33%)        8 (5.97%)          0.4873
  Wound infection (chest)                    2 (2.1%)         1 (0.7%)           0.3781
  Bronchopneumonia                           5 (5.21%)        7 (5.22%)          0.9958
  Sepsis                                     2 (2.08%)        1 (0.75%)          0.3781
  Delirium/altered levels of consciousness   7 (7.29%)        12 (8.96%)         0.6513
  Ischemic stroke                            1 (1.04%)        2 (1.49%)          0.7663
  Acute renal failure                        4 (4.17%)        2 (1.49%)          0.2096
  Acute abdomen                              2 (2.08%)        \-                 0.0933
  Pneumothorax/Pneumomediastinum             2 (2.08%)        4 (2.99%)          0.6722
  Anemia                                     26 (27.08%)      22 (16.42%)        0.0497
  Thrombocytopenia                           1 (1.04%)        3 (2.24%)          0.4934
  Hemodynamic instability                    10 (10.42%)      7 (5.22%)          0.1377
  Pericarditis                               1 (1.04%)        4 (2.99%)          0.3189
  Cardiopulmonary arrest                     4 (4.2%)         4 (3%)             0.6296
  Acute myocardial infarction                1 (1.04%)        2 (1.49%)          0.7663
  Circulatory shock                          4 (4.17%)        3 (2.24%)          0.4013
  Intra-aortic balloon                       \-               1 (0.75%)          0.3963
  Time of Coronary Care Unit (days)          (3.21±2.23)      (3.22±2.7)         0.9619
  Length of hospital stay (days)             (8.19±7.35)      (7.93±3.99)        0.7513
  Mortality                                  6 (6.3%)         3 (2.2%)           0.1218

In the off-pump group, 18 (13.43%) patients developed AF in the postoperative period, while in the on-pump group, 19 (19.79%) developed this arrhythmia, with no significant difference (*P*=0.1955).

Relations between the main risk factors for the development of AF in the postoperative period and the occurrence of this arrhythmia in the groups studied are described in [Tables 4](#t05){ref-type="table"} and [5](#t06){ref-type="table"}.

###### 

Association of the variables with groups that have and have not developed postoperative atrial fibrillation in patients undergoing off-pump CABG.

  Variables                               Developed atrial fibrillation (n=18)   Not developed atrial fibrillation (n=116)   *P* Value
  --------------------------------------- -------------------------------------- ------------------------------------------- -----------
  Preoperative                                                                                                                
  Female                                  6 (33.3%)                              27 (23.3%)                                  0.3568
  Age (\> 70 years)                       4 (22.2%)                              5 (4.3%)                                    0.0047
  Hypertension                            5 (27.8%)                              22 (19%)                                    0.3858
  Diabetes Mellitus                       9 (50%)                                38 (32.8%)                                  0.1538
  Chronic obstructive pulmonary disease   1 (5.6%)                               12 (10.3%)                                  0.5230
  Non-use of beta-blocker                 6 (33.3%)                              17 (14.7%)                                  0.0505
  Non-use of statins                      2 (11.1%)                              12 (10.3%)                                  0.9212
  Intraoperative                                                                                                              
  Blood products                          5 (27.8%)                              23 (19.8%)                                  0.4402
  Arrhythmias                             4 (22.2%)                              19 (16.4%)                                  0.5408
  Atrial fibrillation                     3 (16.7%)                              5 (4.3%)                                    0.0410
  Ventricular fibrillation                3 (16.7%)                              7 (6.1%)                                    0.1135
  Ventricular extrasystole                0 (0%)                                 2 (1.7%)                                    0.5729
  Sinus tachycardia                       0 (0%)                                 2 (1.7%)                                    0.5729
  Postoperative                                                                                                               
  Time of Coronary Care Unit (days)       (4.72±3.32)                            (2.91±2.25)                                 0.0374
  Length of hospital stay (days)          (9.89±4.09)                            (7.62±3.91)                                 0.0244
  Non-use of beta-blocker                 2 (11.1%)                              14 (12.1%)                                  0.9072
  Non-use of statins                      2 (11.1%)                              5 (4.3%)                                    0.2276
  Vasoactive drugs                        13 (72.2%)                             63 (54.3%)                                  0.1536
  Infectious complications                2 (11.1%)                              6 (5.2%)                                    0.3225
  Mortality                               0 (0%)                                 3 (2.6%)                                    0.4902

###### 

Association of the variables with groups that have and have not developed postoperative atrial fibrillation in patients undergoing on-pump CABG.

  Variables                               Developed atrial fibrillation (n=19)   Not developed atrial fibrillation (n=77)   *P* Value
  --------------------------------------- -------------------------------------- ------------------------------------------ -----------
  Preoperative                                                                                                               
  Female                                  5 (26.3%)                              18 (23.7%)                                 0.8107
  Age (\> 70 years)                       6 (31.6%)                              5 (6.5%)                                   0.0021
  Hypertension                            8 (42.1%)                              16 (20.8%)                                 0.0545
  Diabetes Mellitus                       5 (26.3%)                              25 (32.5%)                                 0.6044
  Chronic obstructive pulmonary disease   2 (10.5%)                              6 (7.8%)                                   0.6994
  Non-use of beta-blocker                 0 (0%)                                 9 (11.7%)                                  0.1175
  Non-use of statins                      1 (5.3%)                               8 (10.4%)                                  0.4923
  Intraoperative                                                                                                             
  Aortic clamping time                    (67.11±17.18)                          (69.41±21.26)                              0.66299
  Cardiopulmonary bypass time             (100±23.69)                            (104.41±26.6)                              0.51121
  Blood products                          12 (63.2%)                             50 (64.9%)                                 0.8847
  Arrhythmias                             2 (10,5%)                              7 (9.1%)                                   0.8476
  Atrial fibrillation                     1 (5.3%)                               0 (0%)                                     0.0430
  Ventricular fibrillation                1 (5.3%)                               3 (3.9%)                                   0.7894
  Ventricular extrasystole                0 (0%)                                 1 (1.3%)                                   0.6175
  Sinus tachycardia                       0 (0%)                                 0 (0%)                                     \-
  Postoperative                                                                                                              
  Time of Coronary Care Unit (days)       (4.53±3.11)                            (2.89±1.69)                                0.0652
  Length of hospital stay (days)          (10.26±11.26)                          (7.68±6.01)                                0.3440
  Increased bleeding                      2 (10.5%)                              3 (3.9%)                                   0.2441
  Non-use of beta-blocker                 5 (26.3%)                              6 (7.8%)                                   0.0232
  Non-use of statins                      2 (10.5%)                              3 (3.9%)                                   0.2441
  Vasoactive drugs                        14 (73.7%)                             43 (55.8%)                                 0.1562
  Infectious complications                4 (21.1%)                              4 (5.2%)                                   0.0251
  Mortality                               4 (21.1%)                              2 (2.6%)                                   0.0029

Among the preoperative risk factors, age over 70 years old is strongly associated with the development of AF in both groups (22.2%; *P*=0.0047 in the off-pump group and 31.6% in the on-pump group; *P*=0.0021). There was a tendency in developing this arrhythmia in the on-pump group patients with hypertesion (42.1%; *P*=0.0545), although this was not statistically significant. Similarly, analyzing the non-use of beta-blocker drugs, the off-pump group had a tendency to develop AF (33.3%; *P*=0.0505).

Amongst the intraoperative risk factors, only the presence of AF during surgery showed relation to the development of this arrhythmia in the postoperative period in both groups, on-pump CABG (5.3%; *P*=0.0430) and off-pump (16.7%; *P*=0.0410).

Amongst the postoperative risk factors in the off-pump group, CCU time and hospital stay were remarkably higher in patients who developed AF (4.72±3.32; *P*=0.0374 and 9.89±4.09; *P*=0.0244, respectively) when compared to those who did not develop this arrhythmia. Analyzing the non-use of beta-blocker drugs, there was a strong association with the development of AF in the on-pump group (26.3%; *P*=0.0232). This group showed expressive relationship between the presence of infectious complications and the development of this arrhythmia (21.1%; *P*=0.0251).

The overall mortality of 230 patients undergoing CABG was 3.91%. Six (6.3%) out of the 96 patients in the on-pump group died, compared to 3 (2.2%) out of 134 patients in the off-pump group (P=0.1218). Mortality in the on-pump group was notably higher in patients who developed AF when compared to patients who did not develop the arrhythmia (21.1%; *P*=0.0029). No deaths were observed in patients undergoing off-pump CABG that developed postoperative AF.

DISCUSSION
==========

Atrial fibrillation is the most common arrhythmia in the postoperative period of patients undergoing CABG^\[[@r13],[@r14]\]^. The presence of this arrhythmia is associated with longer clinical recovery time, besides being able to worsen the hemodynamic state of the patient, to increase the risk of congestive heart failure and trigger thromboembolic events^\[[@r05],[@r14],[@r15]\]^. The increased morbidity and the consequent prolongation of hospitalization significantly increase the hospital costs^\[[@r14],[@r15]\]^.

Unlike non-surgical cases, the AF in the postoperative period does not have a well-defined cause, but recent studies suggest multifactorial mechanism, involving: oxidative stress, inflammation, atrial fibrosis, changes in autonomic tonus and connexin expression, that increase the dispersion of atrial refractoriness and favor the formation of a proarrhythmic substrate^\[[@r16]\]^.

Some risk factors are related to increased incidence of AF in the postoperative period of cardiac surgery. Among these factors are: paroxysmal AF history, previous myocardial infarction, DM, hypertension, COPD, discontinuation of beta-adrenergic drugs preceding surgery, aortic clamping time, postoperative ischemia and vasoactive amines^\[[@r16]\]^. Advanced age is one of the most important factors being considered an independent predictor of this arrhythmia after CABG^\[[@r02],[@r16]\]^.

Studies showed the use of CPB as an important risk factor involved in the development of AF, which can be explained by the resulting ischemia of cardioplegia, the CPB time, as well as the cannulation and aortic clamping^\[[@r04],[@r13],[@r17]\]^. In addition, blood contact with non-physiological surfaces of CPB machine results in an inflammatory response that may also be involved in the development of AF^\[[@r04],[@r13],[@r17]\]^. In view of these aspects, it is expected that off-pump CABG be associated with a lower incidence of AF in the postoperative period. Although some studies show such benefit^\[[@r13]\]^, they are still controversial.

In a comparative study between on-pump and off-pump CABG, the on-pump group had major complications, such as stroke, reoperation for bleeding, prolonged mechanical ventilation, AF and period of hospitalization^\[[@r18]\]^. Some well-designed clinical trials comparing the two techniques showed no significant difference in the incidence of arrhythmias, especially of AF^\[[@r15],[@r19]\]^.

In this study, the overall incidence of AF after CABG was 16.1%, similar that found in other studies^\[[@r14],[@r16]\]^. However, there was no significant difference in the incidence of AF between groups, being 13.43% in the off-pump group and 19.79% in the on-pump group (*P*=0.1955). These results were similar those found in other studies^\[[@r14],[@r15]\]^.

Lin et al.^\[[@r14]\]^ observed that off-pump CABG also did not reduce the incidence of postoperative AF. The authors believe that the results can be explained by the greater use of beta-blockers in the preoperative period for the on-pump group. It is believed that the use of beta-blockers preoperatively is an effective measure for the prophylaxis of AF^\[[@r02],[@r12],[@r16]\]^. In our study, the on-pump group also showed greater use of beta-blocker drugs preoperatively, compared to the off-pump group (90.6% and 82.8%, respectively), but these results were not statistically significant (*P*=0.0923).

A notable increase in cases of AF in patients over 70 was identified, regardless of the method used for myocardial revascularization, and it is the preoperative variable statistically relevant among the analyzed. It is estimated that for each decade of life, there is a 75% increase in the odds of developing AF in the postoperative period^\[[@r20]\]^. Thus, anyone over 70 has a high risk of developing AF^\[[@r20]\]^. Aging causes degenerative changes in the atrial myocardium, leading to changes in the electrical characteristics of the sinus and AV nodes, which contributes to fragment the impulse propagation^\[[@r21]\]^. In these patients, the atrium is generally dilated, hypertrophic and/or with fibrosis areas, compromising the structure and function of the sinus node^\[[@r16]\]^. Often, patients older than 70 years-old are carriers of atherosclerosis, hypertension and/or diabetes mellitus, in addition to having reduced cardiopulmonary reserve as to the younger, contributing greatly to the genesis of AF^\[[@r16]\]^.

In perioperative period, we found in both groups, the occurrence of AF in this period is a predictor for recurrence postoperatively, which is not observed in other analyzed arrhythmias. It is known that prior AF is a risk factor for development of AF in the postoperative period^\[[@r04],[@r16]\]^. It is speculated that vulnerable individuals with AF, present electrophysiological pro-arrhythmic substrate, which is then exacerbated by surgery^\[[@r04]\]^. Therefore, the occurrence of AF during surgery could expose susceptible individuals with great potential for recurrence postoperatively. Also, the arrhythmia during surgery can result from individuals with paroxysms of AF with spontaneous resolution which were undiagnosed.

In the postoperative period, we observed the association of non-use of beta-blocker drugs and the development of postoperative AF in on-pump group. Some studies^\[[@r03],[@r21],[@r22]\]^ showed beta-blockers are effective in preventing postoperative AF. It is believed that the increased sympathetic tonus may predispose patients to the development of AF, and therefore, beta-blockers can prevent this arrhythmia to modulate this pathway^\[[@r13]\]^.

Previous studies have shown that the presence of AF postoperative can increase hospitalization in 2-4 days, thus increasing the cost of treatment^\[[@r23]\]^. This study showed that the development of postoperative AF in the off-pump CABG is associated with increased length of stay in the CCU and longer total hospitalization compared to patients who did not develop AF. However, there was no statistical difference in mortality to the same group. The on-pump group showed no significant difference in the length of stay, but showed higher mortality in patients who developed AF compared to those who did not develop the arrhythmia. This can be explained by the fact that patients undergoing CABG with CPB had higher rates of infectious complications.

The overall mortality in this study was 3.91%, comparable to the study of Sá et al.^\[[@r24]\]^ which showed a mortality of 3.5% for patients classified as moderate risk (EuroSCORE 3-5). As well as the results of the study of Shroyer et al.^\[[@r25]\]^, we found no statistical difference in mortality between on-pump and off-pump CABG.

CONCLUSION
==========

Off-pump CABG did not reduce the incidence of AF in the postoperative period. We identified as predictors of risk for developing this arrhythmia: patients older than 70 years-old and the presence of AF in the perioperative period in both groups, and non-use of beta-blocker drugs postoperatively in on-pump group.
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